JP2016529306A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529306A5
JP2016529306A5 JP2016539571A JP2016539571A JP2016529306A5 JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5 JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5
Authority
JP
Japan
Prior art keywords
alkyl
cyano
hydroxyl
disease
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539571A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408008B2 (ja
JP2016529306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069088 external-priority patent/WO2015032945A1/en
Publication of JP2016529306A publication Critical patent/JP2016529306A/ja
Publication of JP2016529306A5 publication Critical patent/JP2016529306A5/ja
Application granted granted Critical
Publication of JP6408008B2 publication Critical patent/JP6408008B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539571A 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物 Active JP6408008B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13183519 2013-09-09
EP13183519.1 2013-09-09
EP14151979 2014-01-21
EP14151979.3 2014-01-21
PCT/EP2014/069088 WO2015032945A1 (en) 2013-09-09 2014-09-08 Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors

Publications (3)

Publication Number Publication Date
JP2016529306A JP2016529306A (ja) 2016-09-23
JP2016529306A5 true JP2016529306A5 (enExample) 2017-10-12
JP6408008B2 JP6408008B2 (ja) 2018-10-17

Family

ID=51535425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539571A Active JP6408008B2 (ja) 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物

Country Status (10)

Country Link
US (1) US9856228B2 (enExample)
EP (1) EP3044214B1 (enExample)
JP (1) JP6408008B2 (enExample)
CN (1) CN105612149A (enExample)
AU (1) AU2014317048B2 (enExample)
CA (1) CA2923484C (enExample)
DK (1) DK3044214T3 (enExample)
EA (1) EA029030B1 (enExample)
SG (1) SG11201601150WA (enExample)
WO (2) WO2015032943A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105612149A (zh) 2013-09-09 2016-05-25 普罗技迈克斯公司 作为二肽基肽酶i抑制剂的肽基腈化合物
NO2699580T3 (enExample) 2014-01-24 2018-02-24
DK3265452T3 (en) * 2015-03-05 2020-06-08 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors
ES2912276T3 (es) * 2015-04-07 2022-05-25 Ela Pharma Ltd Composiciones para tratar y/o prevenir necrosis celular o tisular que seleccionan como diana específicamente catepsina C y/o CELA1 y/o CELA3A y/o enzimas estructuralmente relacionadas con las mismas
PT3758708T (pt) 2018-03-01 2025-02-13 Astrazeneca Ab Composições farmacêuticas compreendendo (2s)-{(1,s)-1-ciano-2-[4-(3-metil-2-oxo-2,3-di-hidro-1,3-benzoxazol-5-il)fenil]etil}-1,4-oxazepano-2-carboxamida
CA3106269A1 (en) 2018-07-17 2020-01-23 Insmed Incorporated Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis
AU2021314104A1 (en) 2020-07-20 2023-01-19 Insmed, Inc. Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditions
CN114159446A (zh) 2020-09-11 2022-03-11 中国科学院上海营养与健康研究所 组织蛋白酶c抑制剂在治疗肿瘤转移中的应用
WO2023243601A1 (ja) 2022-06-13 2023-12-21 モジュラス株式会社 アザシクロアルキルカルボニル環状アミン化合物
JP2026503035A (ja) 2023-01-06 2026-01-27 インスメッド インコーポレイテッド 新規な可逆性dpp1阻害剤及びその用途
WO2025162472A1 (en) 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof
WO2026148258A2 (en) 2025-01-03 2026-07-09 Insmed Incorporated Dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902181B2 (en) * 2007-12-12 2011-03-08 Astrazeneca Ab Compounds 010
KR100903499B1 (ko) 2007-12-27 2009-06-18 엔에이치엔비즈니스플랫폼 주식회사 검색 의도 분류에 따른 광고 제공 방법 및 상기 방법을수행하기 위한 시스템
EA201190235A1 (ru) * 2009-05-07 2012-05-30 Астразенека Аб Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
WO2010142985A1 (en) * 2009-06-10 2010-12-16 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
WO2011154677A1 (en) 2010-06-09 2011-12-15 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760
WO2012119941A1 (en) * 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
WO2012130299A1 (en) 2011-03-30 2012-10-04 Prozymex A/S Peptidase inhibitors
US8999975B2 (en) 2011-09-19 2015-04-07 Boehringer Ingelheim International Gmbh Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
CN105612149A (zh) 2013-09-09 2016-05-25 普罗技迈克斯公司 作为二肽基肽酶i抑制剂的肽基腈化合物

Similar Documents

Publication Publication Date Title
JP2018507223A5 (enExample)
JP2018535967A5 (enExample)
JP2019524883A5 (enExample)
JP2018534348A5 (enExample)
JP2016525130A5 (enExample)
JP2017523225A5 (enExample)
JP2014097964A5 (enExample)
JP2010530897A5 (enExample)
JP2014511891A5 (enExample)
JP2017530959A5 (enExample)
JP2018510139A5 (enExample)
JP2015508103A5 (enExample)
JP2016510326A5 (enExample)
JP2016500111A5 (enExample)
JP2020532547A5 (enExample)
JP2010524932A5 (enExample)
JP2015024998A5 (enExample)
JP2014515351A5 (enExample)
JP2011037841A5 (enExample)
JP2014528403A5 (enExample)
FI3562487T3 (fi) Metalloentsyymi-inhibiittoriyhdisteitä
JP2017514910A5 (enExample)
JP2016511753A5 (enExample)
JP2018538273A5 (enExample)
JP2017508733A5 (enExample)